↓ Skip to main content

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

Overview of attention for article published in Journal of Hematology & Oncology, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

policy
2 policy sources
twitter
5 X users

Citations

dimensions_citation
151 Dimensions

Readers on

mendeley
114 Mendeley